West Pharmaceutical Services WST Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
Based on trailing twelve months.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's gross margin?
- West Pharmaceutical Services (WST) reported gross margin of 36.3% in Q1 2026.
- How has West Pharmaceutical Services's gross margin changed year-over-year?
- West Pharmaceutical Services's gross margin increased by 5.0% year-over-year, from 34.5% to 36.3%.
- What is the long-term trend for West Pharmaceutical Services's gross margin?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's gross margin has grown at a -2.9% compound annual growth rate (CAGR), from 158.9% to 141.3%.
- What does gross margin mean?
- How much of every sales dollar is left after the direct cost of what was sold.
- How do you interpret gross margin?
- Higher and stable gross margins indicate pricing power and a durable cost structure. A declining trend signals input-cost pressure, pricing competition, or a shift toward lower-margin products.
- How does gross margin compare across companies?
- Highly comparable within an industry, less so across industries — software runs 70%+ while distributors run in single digits. Track the trend more than the absolute level across sectors.